SK280929B6 - Substituované 3-metylén-2-oxindol-1-karboxamidy, ich použitie a farmaceutické prostriedky na ich báze - Google Patents

Substituované 3-metylén-2-oxindol-1-karboxamidy, ich použitie a farmaceutické prostriedky na ich báze Download PDF

Info

Publication number
SK280929B6
SK280929B6 SK912-95A SK91295A SK280929B6 SK 280929 B6 SK280929 B6 SK 280929B6 SK 91295 A SK91295 A SK 91295A SK 280929 B6 SK280929 B6 SK 280929B6
Authority
SK
Slovakia
Prior art keywords
formula
alkyl
group
carboxamides
methylene
Prior art date
Application number
SK912-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK91295A3 (en
Inventor
Wayne E. Barth
Kelvin Cooper
Edward F. Kleinman
Lawrence A. Reiter
Ralph P. Robinson
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of SK91295A3 publication Critical patent/SK91295A3/sk
Publication of SK280929B6 publication Critical patent/SK280929B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
SK912-95A 1993-01-26 1993-10-20 Substituované 3-metylén-2-oxindol-1-karboxamidy, ich použitie a farmaceutické prostriedky na ich báze SK280929B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/009,188 US5270331A (en) 1993-01-26 1993-01-26 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
PCT/US1993/009813 WO1994017061A1 (en) 1993-01-26 1993-10-20 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides

Publications (2)

Publication Number Publication Date
SK91295A3 SK91295A3 (en) 1995-12-06
SK280929B6 true SK280929B6 (sk) 2000-09-12

Family

ID=21736103

Family Applications (1)

Application Number Title Priority Date Filing Date
SK912-95A SK280929B6 (sk) 1993-01-26 1993-10-20 Substituované 3-metylén-2-oxindol-1-karboxamidy, ich použitie a farmaceutické prostriedky na ich báze

Country Status (35)

Country Link
US (1) US5270331A (ko)
EP (1) EP0681580B1 (ko)
JP (1) JP2703825B2 (ko)
KR (1) KR0169827B1 (ko)
CN (1) CN1052003C (ko)
AP (1) AP443A (ko)
AT (1) ATE155137T1 (ko)
AU (1) AU678187B2 (ko)
BR (1) BR9307768A (ko)
CA (1) CA2152919C (ko)
CZ (1) CZ181995A3 (ko)
DE (1) DE69312093T2 (ko)
DK (1) DK0681580T3 (ko)
EG (1) EG20302A (ko)
ES (1) ES2104187T3 (ko)
FI (1) FI940365A (ko)
GR (1) GR3024591T3 (ko)
HR (1) HRP940034B1 (ko)
HU (1) HUT69689A (ko)
IL (1) IL108384A (ko)
MA (1) MA23096A1 (ko)
MX (1) MX9400677A (ko)
MY (1) MY138629A (ko)
NO (1) NO952949D0 (ko)
NZ (1) NZ257278A (ko)
OA (1) OA10563A (ko)
PL (1) PL178857B1 (ko)
RU (1) RU2124514C1 (ko)
SI (1) SI9300567A (ko)
SK (1) SK280929B6 (ko)
TW (1) TW330935B (ko)
UA (1) UA41348C2 (ko)
WO (1) WO1994017061A1 (ko)
YU (1) YU48796B (ko)
ZA (1) ZA94463B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2155664C (en) * 1993-02-09 1999-06-15 Ralph P. Robinson Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-(n-carboxamido)carboxamides as antiinflammatory agents
WO1997013767A1 (de) * 1995-10-09 1997-04-17 Chemisch Pharmazeutische Forschungsgesellschaft Mbh Heterocyclisch substituierte 1-indolcarboxamide als cyclooxygenase-2 inhibitoren
WO1999044608A1 (en) * 1998-03-06 1999-09-10 Astrazeneca Ab New use
EP0984012A3 (en) * 1998-08-31 2001-01-10 Pfizer Products Inc. Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
AU2002325614A1 (en) * 2001-08-16 2003-03-03 Pharmacon-Forschung Und Beratung Gmbh Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances
CN101628842A (zh) * 2009-08-27 2010-01-20 中国人民解放军防化指挥工程学院 烷氧羰基甲氧基作为羧基保护基

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE68923673T2 (de) * 1988-10-18 1996-01-18 Pfizer Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden.
HU208421B (en) * 1988-10-18 1993-10-28 Pfizer Process for producing starting materials for producing 3-acyl-2-oxindol-carboxamides ofantiphlogistic activity

Also Published As

Publication number Publication date
TW330935B (en) 1998-05-01
EG20302A (en) 1998-10-31
FI940365A (fi) 1994-07-27
JP2703825B2 (ja) 1998-01-26
BR9307768A (pt) 1995-11-21
YU48796B (sh) 2000-03-21
SI9300567A (en) 1994-09-30
KR0169827B1 (en) 1999-01-15
WO1994017061A1 (en) 1994-08-04
EP0681580B1 (en) 1997-07-09
PL309989A1 (en) 1995-11-13
CA2152919C (en) 1999-01-05
DE69312093D1 (de) 1997-08-14
CN1052003C (zh) 2000-05-03
OA10563A (en) 2002-06-05
NO952949L (no) 1995-07-25
IL108384A (en) 1998-12-27
GR3024591T3 (en) 1997-12-31
MX9400677A (es) 1994-08-31
HRP940034B1 (en) 2000-10-31
SK91295A3 (en) 1995-12-06
RU2124514C1 (ru) 1999-01-10
NO952949D0 (no) 1995-07-25
IL108384A0 (en) 1994-04-12
JPH08501316A (ja) 1996-02-13
RU95117091A (ru) 1997-06-27
AU678187B2 (en) 1997-05-22
MY138629A (en) 2009-07-31
ZA94463B (en) 1995-07-24
HRP940034A2 (en) 1996-08-31
NZ257278A (en) 1996-09-25
MA23096A1 (fr) 1994-10-01
US5270331A (en) 1993-12-14
HUT69689A (en) 1995-09-28
AP443A (en) 1996-01-03
HU9400209D0 (en) 1994-05-30
KR960700244A (ko) 1996-01-19
YU2994A (sh) 1997-01-08
ES2104187T3 (es) 1997-10-01
AP9300583A0 (en) 1993-10-31
CN1097740A (zh) 1995-01-25
CZ281046B6 (cs) 1996-06-12
FI940365A0 (fi) 1994-01-25
DE69312093T2 (de) 1997-10-30
CZ181995A3 (en) 1996-06-12
CA2152919A1 (en) 1994-08-04
EP0681580A1 (en) 1995-11-15
UA41348C2 (uk) 2001-09-17
AU5359894A (en) 1994-08-15
DK0681580T3 (da) 1997-08-18
ATE155137T1 (de) 1997-07-15
PL178857B1 (pl) 2000-06-30

Similar Documents

Publication Publication Date Title
EP2281815B1 (en) 4-(Acetylamino)-3-[(4-chlorophenyl)thio]-2-methyl-1H-indole-1-acetic acid ethyl ester intermediate compound
WO2009050227A1 (en) Pyridazine derivatives for inhibiting beta amyloid peptide production
EP3376870B1 (en) Process for the preparation of kinase inhibitors and intermediates thereof
CA2178352A1 (en) Thiazolo benzazepine containing dual action inhibitors
WO1987000836A1 (en) Pharmaceutically active 2-thiomethyl-substituted-1,4-dihydropyridines
US6281228B1 (en) Heterocyclic inhibitors of microsomal triglyceride transfer protein and method
EP0388309B1 (fr) Nouveaux dérivés du 1h,3h-pyrrolo [1,2-c] thiazolecarboxamide-7, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5594006A (en) Carbostyril derivatives as matrix metalloproteinases inhibitors
JPH08509488A (ja) 複素環式誘導体
SK280929B6 (sk) Substituované 3-metylén-2-oxindol-1-karboxamidy, ich použitie a farmaceutické prostriedky na ich báze
JP2008517907A (ja) 新規な使用
US5106860A (en) Thiazolidin-4-one derivatives and acid addition salts thereof useful for treating paf mediated diseases
WO2001012601A1 (fr) Derives d'anilide ou sels correspondants, et medicaments a base de ces derives
KR20190015305A (ko) 신장 외수질 칼륨 채널 억제제로서 약학적으로 허용 가능한 염
GB2264115A (en) 1h-2-methylimidazo(4,5-c)pyridinyl derivatives as paf antagonists
FR2485016A1 (fr) Derives d'acide phosphonique de ((amino-2 thiazolyl-4) oximino)-7 cephalosporines, utiles notamment comme medicaments antibacteriens
JPH0592948A (ja) プロピオン酸アミド誘導体およびその医薬用途
EP0251827B1 (en) New cyclic ether derivatives, their preparation and their use
EP0124384A1 (fr) Nouveaux dérivés du pyrrole orthocondensé utiles pour la préparation de nouveaux médicaments et leur préparation
HUT72636A (en) Optically active thiomorpholino-carbonyl-derivatives and pharmaceutical compositions containing them
WO2003104240A1 (ja) 環状チオエーテル類の製造法及びその合成中間体
JP2008524189A (ja) 新規ベンズアミド化合物
KR800001611B1 (ko) 1, 4-디하이드로피리딘 유도체의 제조방법
KR800001591B1 (ko) 1, 4-디하이드로 피리딘 유도체의 제조방법
WO2024054840A1 (en) Macrocyclic compounds, compositions, and methods of using thereof